Visualising when and where calcium appears and disappears in cardiomyocytes is a major goal of cardiovascular research. Surprisingly we find that the chemical dyes widely used for this purpose disrupt cell contractility, due at least in part due to direct inhibition of the acto-myosin ATPase required to generate force. In order to improve calcium detection methods, we have developed a genetically encoded indicator that sits within the myofilament to directly visualise the changes occurring at the sarcomere. This tool improves on established chemical dyes and untargeted genetically encoded indicators for analysing small molecule modulators of myofilament-based calcium signalling. Importantly this is achieved without any measurable change in contractile function.
binds to Troponin C (TnC), promoting co-operative activation of the thin filament 2, 3 allowing the rigid actin scaffold to interact with the motor protein myosin enabling ATP dependent contraction 4, 5 . Relaxation occurs as Ca ++ is removed from the myofilament and repackaged into the SR, or pumped out of the cell, for subsequent cycles.
Protein architecture within the sarcomere is highly ordered and densely packed, producing a diffraction based striation pattern in unstained cells. Sarcomeric proteins are subject to point mutations and truncations in the common inherited heart diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathy that change myofilament Ca ++ sensitivity and/or contractility 6, 7 . Modulators of contractility therefore represent potential therapies for these conditions, as well as the growing problem of heart failure 8 in general. Importantly these should act without changes to total [Ca ++ ] which is potentially pro-arrhythmic 9 . Therefore, to understand these diseases and identify such compounds, a need for myofilament [Ca ++ ] and contractility assessment exists where ideally; measurement of one parameter does not alter the other.
Chemical dyes based on the non-fluorescent Ca However, recent work has highlighted direct inhibition of the Na/K ATPase in many cell types by the BAPTA family of Ca ++ indicators 11 which limits cell survival and may reduce ATP dependent force production. Indeed fura2-based impairment of contractility has previously been observed in isolated rat cardiac trabeculae 12 .
Genetically encoded calcium indicators (GECIs) offer an alternative strategy for [Ca ++ ] assessment 13 , with the possibility of subcellular targeting and lower (~μM) expression levels.
However, their uptake in cardiovascular research has been slow 13 compared to neurobiology 14, 15 as primary cardiomyocytes are difficult to transfect, and tend not to survive long enough in culture for gene expression and chromophore maturation. One highly desirable location for a Ca ++ indicator is in the sarcomere, where calcium regulates contractility.
Myofilament specific probes however remain elusive, in part due to the concern that the bulky 30x40x70Å adducts of the smallest GECIs 16 may be poorly tolerated by the paracrystaline sarcomeric environment 7, 17 leading to perturbed function of the indicator, the fusion partner, or the cell.
Here we document the adverse effects on contractility of a number of chemical dyes widely used in cardiovascular research and go on to describe production and validation of a thin filament restricted GECI, RGECO-TnT. This novel Ca ++ sensor, not only avoids any disruption of contractility, but also provides additional mechanistic information about Ca ++ handling in the myofilament compared to an unrestricted RGECO when drugs that target the myofilament are used.
Results
In a photometric system designed to minimise dye use and light exposure, we found the use of fura2 to measure [Ca ++ ] in isolated ventricular adult guinea pig cardiomyocytes (vGPCMs) caused progressive inhibition of contractility across the dose range used in imaging studies (Figure 1a, b, Supplementary Figure 1) . Impairment of fractional shortening may be caused by direct Ca ++ chelation (fura2 Kd =145nM); as although the external concentration of fura2-AM ester is 1 μM, after ester hydrolysis fura2 becomes polar and cannot diffuse out of the cell leading to accumulation. Concentrations ranging between 0.1 and 40mM have been reported within cells 18, 19 . Surprisingly, we also find inhibitory effects on whole-cell contractility with a chemical indicator of voltage, fluovolt 20 , and the sodium indicator SBFI 21 ( Figure 1c,d,e,f) . These dyes do not bind Ca ++ but do require weak surfactant application with or without acetoxymethyl esterification, and thus these data suggest there may also be Ca Figure 2) limiting the utility of motion tracking contractility assessments 22 with simultaneous fura2 Ca ++ imaging. Observer-independent impedance assessments of iPS-CM contractility can be undertaken without extrinsic illumination 23 . We find that contractile suppression is detected in the presence of green-shifted calcium indicators on monolayer iPSCMs from a different vendor (Supplementary Figure 3) ; suggesting that neither UV light excitation phototoxicity occurring during fura2 imaging, nor cell singularisation, or indeed particular dyes or cell suppliers are required for this phenomenon. This suggests instead, that it may be due to direct biochemical effects of this group of compounds.
Protein based calcium indicators, the GECI's, have been iteratively developed alongside improvements in fluorescent proteins over the past two decades 24 . Currently in cardiovascular research we lack probes that function where calcium is stored (the SR) and its major functional target (the myofilament). In order to develop a thin filament-restricted GECI we screened fusion proteins of green fluorescent protein (GFP) with various troponin subunits to identify sites that preserve actomyosin ATPase regulation. In contrast to the other fusion proteins tested, we found that GFP conjugated to the N-terminus of Troponin-T does not disrupt Figure 7) , and approximately twice those observed at 25ºC.
When RGECO-TnT is adenovirally expressed in vGPCMs (Figure 3a) or iPS-CMs or optical control tools 16, 26 ; indeed RGECO-TnT can be used simultaneously with the cytoplasmic green Ca There is growing interest in the therapeutic use of small molecule modulators of myofilament contractility 7, 9, 30, 31 . Importantly these should not affect Ca . We also tested the in vitro myofilament ATPase function of TnI as a smaller GFP fusion and found that typical Ca ++ dependence was lost so this tool was not developed further. The discrepancy between these observations may be explained by relative expression levels of the cAMP reporter in adult rat cardiomyocytes, which we assume (as this was not detailed in 36 ) will be lower than the 100 % used in our in vitro assay. Alternatively, the larger FRET reporter may exert less steric hindrance on troponin complex formation and native
ATPase activity than the GFP / GECIs used in this study.
Myofilament targeting appears to enhance reporter sensitivity to the underlying biology.
For example, RGECO-TnT detects larger peak amplitude reductions or increases compared to the other indicators strategies when small molecules that act via the myofilament (MYK-461 and levosimendan) are used. This may result from subcellular proximity of the sensor to site of drug action. The effect of MYK-461 on Ca ++ handling was unexpected. Previous reports using fura2 measurements in isolated rat cardiomyocytes showed no effect on Ca dynamics. Whilst all three sensors detect changes to T50 off times, neither fura2 nor unrestricted RGECO reported changes to T50 on rates. However, the myofilament restricted sensor appears able to identify these subtle changes.
Both GECIs offer significant advances during combined assessments of contractility.
While the presence of GECIs had no significant effect on sarcomere shortening, fura2 loaded cells relax and contract less and demonstrate composite effects due to the action of both fura2
and drug being tested. 
METHODS

Adenoviral Virus design and production
Recombinant adenoviral constructs were created using the AdEasy XL recombination system (Agilent technologies) as previously described taurine, 5mM creatine, 5mM MgCl2, 5mM Na pyruvate, 4.5mM KCl, 1mM NaH2PO3, pH7.3
with NaOH). Cells were resuspended and plated at ~1x10 5 per ml in ACCITT3 cardiomyocyte culture medium as first described by Ellingsen et al 38 containing 500 ml M199 media 100 units of penicillin, 0.1 mg/ml streptomycin, 20mM taurine, 5mM creatine, 5mM Na pyruvate, 2mg/ml BSA, 2mM L-carnitine, 0.1pM insulin. Recombinant adenovirus was immediately added to 0.75ml of cell suspension to an estimated multiplicity of infection (MOI) of between 500 and 800, infected cells were placed at 37°C in a 5% CO2 atmosphere for 48 hours. This was sufficient to infect 100% of all viable rod shaped cardiomyocytes with either RGECO or RGECO-TnT.
Stem cell derived cardiomyocytes
Human iPS derived cardiomyocytes and maintenance media were purchased from Axol
Bioscience, (Cambridge, UK), and handled according to manufacturer's recommendations at 37ºC, 5% CO2 in a humidified incubator. After 72 hours in culture they were singularised and re-plated onto Fibronectin (0.5%)/Gelatin (0.1%) coated 35mm glass bottom dish (No. 0)
MatTek plates (Ashland, MA, US) at 1:6.
Protein purification
N and C terminal eGFP conjugates of human recombinant TnT and TnC were produced by molecular cloning in PMW172 vector using flanking 3' NdeI and 5' EcoRI restriction sites and an internal HindIII restriction site used as a linker in each case (NEB, New England).
RGECO and RGECO-TnT were also sub-cloned in to PMW172 using the same strategy.
Proteins were expressed in BL21-DE3-pLysS E.coli induced using 0.4mM Isopropyl β-D-1-thiogalactopyranoside for 4 hours. Bacterial pellets were recovered by centrifugation (10,000 xg for 10 mins) and lysed in a buffer containing 25mM Tris HCl, pH 7.5, 20% sucrose, 1mM
EDTA, 200mM NaCl, 5M urea, 0.1% Triton X-100. All proteins were purified using an AKTA-UPC900 FPLC using HiTrap FF chromatography columns (GE Healthcare, Amersham). GFP-TnT and TnT-GFP were purified using sequential cation (in buffer containing 6M urea, 1mM EDTA, 1mM 2-mercaptoethanol, 20mM MOPS, pH 6.0) followed by anion (in buffer containing 6M urea, 1mM EDTA, 1mM 2-mercaptoethanol 50mM Tris HCl pH8.0) exchange chromatography. GFP-TnC and TnC-GFP were purified by anion (pH8.5) exchange chromatography. TnI-GFP was purified by sequential cation and anion exchange chromatography. RGECO and RGECO-TnT were purified using sequential anion (pH8.0) exchange chromatography, Ammonium Sulphate fractionation (to 50% for RGECO and 35% for RGECO-TnT) and finally Hydrophobic Interaction Chromatography (HIC) (in buffer containing 30% ammonium sulphate, 200mM NaCl2 1mM ditiothretol and 30mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES)). Ion exchange columns were eluted using a gradient of 0-2M NaCl, the HIC column was eluted with a gradient of 30-0% ammonium sulphate. All eluted protein fractions were assessed for purity using 12% SDS PAGE gels, stained with coomassie brilliant blue. Wild type human recombinant TnT, TnI, TnC and Ala-Ser-α-TM 39 were purified as previously described 40 . Troponin complex containing either WT, GFP-TnT, GFP-TnT, GFP-TnC, TnC-GFP or RGECO-TnT were reconstituted by dialysis into buffer containing 10mM imidazole pH7.0, 1mM DTT, 0.01% azide, 0.1mM CaCl2, 6M urea and 1M KCl, firstly urea was reduced stepwise from to 2 then 0M then KCl was reduced stepwise from 1M to 800 -600 -400 -200mM KCl in a series of 3 hour dialyses. Tn Complex was purified using size exclusion chromatography in 200mM KCl dialysis buffer (Supplementary Figure 5a) , purity was analysed by SDS PAGE (Supplementary Figure 5b) , and finally, purified troponin complexes are dialysed into buffer containing 5mM 1,4-Piperazinediethanesulphate pH7.0, 3,87mM MgCl2, 1mM DTT for
ATPase assay experiments. Actin and myosin-S1 was extracted from rabbit skeletal muscle as previously described 41, 42 .
Actin Co-sedimentation assays
Reconstituted Tn complex proteins (0.5μM) were co-sedimented with human Ala-Ser-α-TM (0.5μM) and rabbit skeletal actin (3.5μM) at 384000xg for 15 mins by ultracentrifugation (Beckman Coulter Inc, High Wycombe). Total, supernatant and pellet fractions were visualized using coomassie blue stained 12% SDS PAGE gels in order to ensure complete reconstitution of thin filaments prior to all ATPase assay measurements. (Supplementary Figure 5c) In vitro acto-myosin activated myosin ATPase assays ATPase assays were undertaken using our standard assay conditions 6, 40 using 3.5μM actin, 0.5μM myosin S1, 0.5μM Ala-Ser-α-TM and 0. 
Determination of Quantum Yield and Molar Extinction Co-efficient
Quantum yield and molar extinction co-efficient was determined for each Ca++ sensor using a method adapted from Zhao et al 25 . Briefly, standards for quantum yield determination were mCherry (for RGECO) and RGECO for RGECO-TnT. Briefly, the concentration of protein in buffer containing 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES), 1.3mM MgCl2 and 1mM dithiothreitol was determined using BCA assay (Pierce) and set to either pCa 4.5 of 8.5, the concentration of each protein was reduced to an absorbance at the excitation wavelength between 0.2 and 0.6. A series of dilutions to absorbance's of 0.01, 0.02, 0.03 and 0.04 were made for each protein solution and standard. The fluorescence emission spectra at Ex F568 of each dilution of each standard and protein solution were recorded using an RF-1501 spectrofluorimeter (Shimadzu, Kyoto, Japan). The total fluorescence intensities were then obtained by integration. Integrated fluorescence intensity vs. absorbance was plotted for each protein and each standard. Quantum yields were determined from the slopes (S) of each line using the equation: Φprotein = Φstandard × (Sprotein/Sstandard).
Extinction coefficients were determined by first measuring the absorption spectrum of both RGECO and RGECO-TnT at pCa8.5 and 4.5 in the buffer above using a plate reader (BMG LABTECH, Offenburg, Germany). Peak Absorbance wavelengths were determined to be A465 in low Ca ++ and A581 in high Ca ++ . Absorbance measurements were automatically converted to 1 cm path length using BMG Omega software. Extinction coefficients of each protein were calculated by dividing the peak absorbance maximum by the previously determined concentration of protein.
Subcellular fractionation and western blotting
Adult guinea pig left ventricular cardiomyocytes were fractionated to recover cytoplasmic and sarcomeric/cytoskeletal samples in a method adapted from Simon et al 43 .
Briefly, 300,000 cardiomyocytes were pelleted by centrifugation, resuspended in buffer containing, 20mM Tris HCl pH7.4, 2mM EDTA, 0.5mM EGTA, 0.3mM sucrose. Cells were homogenised in a glass homogeniser for 1 minute. Cells were pelleted at 1000xg for 5mins, the supernatant / cytoplasmic fraction was retained for SDS PAGE analysis and western blotting. The cell pellet was washed 3 times in fractionation buffer + 1% Triton X-100 each time pelleting the sarcomeric fraction by centrifugation at 1000xg for 5mins. Finally, the sarcomeric fraction was resuspended in fractionation buffer (without Triton X-100) and prepared for SDS PAGE analysis and western blotting. Cytoplasmic and Sarcomeric fractions were western blotted using anti-cTnT (1 in 2000) (Sigma, Poole, UK) and anti-ERK (1 in 4000) (Cell Signaling Technologies, Massachusetts, USA) primary antibodies and rabbit HRP (1 in 8-16000) secondary antibodies using PVDF membranes and visualised and analysed using GelDoc Image Lab software (Bio-Rad Laboratories, California, USA) .
Measurement of sarcomere shortening and fura2 Ca ++ transients
Sarcomere shortening and Ca 
RGECO imaging in fixed cells
Adult ventricular cardiomyocytes were exposed to recombinant adenovirus immediately after isolation in 0.75ml of cell suspension to an estimated multiplicity of infection (MOI) of between 500 and 800, infected cells were placed at 37°C in a 5% CO2 atmosphere for 48 hours. At 48 hours an aliquot was taken and paraformaldehyde to a final concentration of 4% was added, at 10mins cells were pelleted (600rpm, 2mins) in a benchtop centrifuge, washed with 1xPBS and resuspended in PBS. Cells were spun (Cytospin, Thermo Scientific) onto glass slides, and ringed with a PAP pen (Sigma). Human iPS-derived cardiomyocytes were plated as above and incubated to day 7 following thaw before washing with 1xPBS and fixation with 4% paraformaldehyde. For infection, virus was diluted 1:10 from the stock solution and used at 1μl/dish 24 hours after replating. Permeabilisation with 0.1% Triton X-100 in Tris Buffered Saline for 10mins at room temperature was followed by blocking (0.2% albumin in permeabilisation buffer) for 20mins. Primary antibodies (Mouse monoclonal antialpha actinin (Sigma, clone EA-53) rabbit polyclonal anti-DsRed (Clontech) were diluted 1:2000, and 1:200 in blocking buffer respectively. Three hours after primary incubation cells were washed in permeabilisation buffer, and counter stained with Alexa-488 anti-mouse, and Alexa-568 anti-rabbit fab fragment secondary antibodies (Invitrogen), nuclear counterstaining was with TO-PRO-3 (Invitrogen), for an hour before washing and mounting (Vectashield, Vector labs). Images were acquired on a Leica SP5 confocal microscope with a 63x oil immersion lens, and intensity plots prepared with the plot profile function in ImageJ.
Live cell Imaging Microscope
An inverted IX81 frame (Olympus, Japan), with a custom 7 LED array (Cairn Research, Flecainide for 20mins then video rate movies with 0.5Hz pacing were acquired for 28secs using the UPlanFLN 10x lens.
Transient analysis software & statistics
Raw image data was extracted using CellR (Olympus), and analysed in Excel (Microsoft). From a single cell 10 intensity transients over time were extracted and averaged to give a single transient in a 2 second interval per cell; 3 transients were averaged for iPSCMs. Time to 50% contraction, or time to 50% baseline (from peak) was determined from these traces.
Comparative peak intensity analysis was performed using paired control vs drug exposed datasets obtained from the same cell preparation. In brief the ΔF/F measurement described for intensiometric indicators 34 was used.
∆ = −
Where F(t) is the fluorescence intensity at time (t), and F(min) the minimum fluorescence intensity during the 2 second averaged dataset taken to be representative of a single cell.
Comparisons presented in Figure 2b were obtained by dividing or subtracting the relevant value of the paired control population from that of the drug exposed population based on the data in Supplementary tables 3, 4 & 5.
Where relative intensity data is presented, the following calculation was used
= − −
Where I, intensity, is a ratio of the fluorescence signal (F(t)) scaled according to the maximum (F(max)), and minimum (F(min)) response of the cell during the observation.
Unfiltered transient graphs were plotted using KaleidaGraph (Synergy Software), and dot plots with GraphPad Prism (GraphPad software). Groups were compared using unpaired 
Predictive structural modelling
The predicted models for the RGECO-TnT fusion were generated using RaptorX in (a,c,e) . Control (grey) was compared to cells loaded with 0.1μM (royal blue), 0.5μM (blue), 1.0μM (teal) or 5.0μM (mauve) fura2-AM ester (a). or with 1/1000 dilution of Fluovolt-AM ester (green) loaded according to the manufacturers instructions (c) or with 0.1μM (brown), 0.5μM (red), 1.0μM (orange) or 5.0μM (yellow) SBFI-AM ester (e). Significant reduction in fractional shortening was observed in each case (b).Working concentrations of Fluovolt-AM ester reduced contractile magnitude and caused basal relaxation of cardiomyocytes (d). Exposure to increasing concentrations of the sodium dye SBFI-AM ester also reduced contractile magnitude however did not affect basal relaxation of cardiomyocytes (f). Myofilament function was assessed using in vitro actin activated acto-myosin S1 ATPase assays. Myofilaments containing wild type control Tn complexes in DMSO (grey) were compared to those in the presence of 1μM (blue) or 5μM (mauve) fura2-AM ester. Figure 13) submitted, returns all amino acid sequence of RGECO conjugated to amino acids 1-10 and 187-288 of human cardiac troponin T including the Gly-Ser linker. This indicates the C terminal T2 head thought to be essential for Tn reconstitution was freely available for interaction with the remaining Tn subunits (a). Myofilament function was assessed using in vitro actin activated acto-myosin S1 ATPase assays in (b). The Ca ++ sensitivity of control (unconjugated) troponin complexes (grey lines) were not significantly different to thin filaments reconstituted with RGECO-TnT (purple lines) in paired experiments. n=5 error bars are ±SEM. The steady state Ca ++ binding affinity (K d ) of purified recombinant RGECO (red lines) was compared to RGECO-TnT (purple lines) was assessed by analysis of the fluorescence/pCa relationship (c). There is no significant difference in the fluorescence/pCa relationship between the two GECIs (n=4), error bars are ± SEM. Steady state fluorescence excitation, emission (peak excitation (Ex) = 564nm) / peak emission (Em) = 581nm) and absorbance spectra were obtained at pCa8.5 (dotted lines) and 4.5 (solid lines) for purified recombinant RGECO-TnT (d and e). All experiments were performed at 37°C, 1.3mM MgCl 2 pH7.3. Resultant molar extinction co-efficient, quantum yield, brightness and dynamic range measurements are given in Supplementary Table 2 . Figure 3 . The red genetically encoded Ca ++ sensor RGECO can be delivered to the myofilament by Troponin-T fusion revealing a dynamic signal from the sarcomere of adult ventricular and iPS derived cardiomyocytes without affecting contractility. In contrast to the diffuse staining of RGECO, adenovirally expressed RGECO-TnT localises to the I band in confocal microscopy of fixed adult ventricular (a) and human iPS derived cardiomyocytes (b); z disks are revealed by α-actinin staining which is green in the merge image. Scale bar = 10μm. Dashed box shows the region expanded in the zoom panel. Intensity profile plots spanning two sarcomeres (three z-discs, ~3.6µm) are shown adjacent to the merge image, α-actinin (green line) labels the z-disc, the Ca ++ indicator (red) is excluded from the Z-disc by TnT fusion. iPS-CMs appear to have different sarcomere morphologies adjacent to the nucleus (white arrow head), or the periphery (zoom panel). Western blot analysis of vGPCMs expressing RGECO-TnT in (c), indicates that 54.3±5.5% (n=5) of endogenous TnT is replaced. Unloaded sarcomere shortening during electrical paced (0.5Hz) of isolated adult cardiomyocytes was used to test cardiac contractile function in vGPCMs by sarcomeric length measurement during contraction (d) or by fractional shortening assessment (e). RGECO (Red) and RGECO-TnT (Purple) infected cells were not significantly different to control (Grey) (e), error bars are ± interquartile range. The trace recordings of change in red fluorescence Ca ++ signal acquired from RGECO-TnT expressing single vGPCMs (f) and iPSCMs (g) imaged at video rate during 0.5Hz electrical pacing. 
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